Mirati Therapeutics
MRTX
#3099
Rank
C$5.58 B
Marketcap
$79.62
Share price
0.00%
Change (1 day)
48.66%
Change (1 year)

Mirati Therapeutics (MRTX) - Cash on Hand

Cash on Hand as of September 2023 : C$1.32 B

According to Mirati Therapeutics's latest financial reports the company has C$1.32 B in cash and cash equivalents.
A companyโ€™s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.

Mirati Therapeutics - Cash on Hand chart (from 2005 to 2023)

Cash on Hand by year

Year Cash on Hand Change
2022-12-31C$1.47 B-22.08%
2021-12-31C$1.88 B6.47%
2020-12-31C$1.77 B229.46%
2019-12-31C$0.53 B77.04%
2018-12-31C$0.30 B60.26%
2017-12-31C$0.18 B148.73%
2016-12-31C$76.24 M-55.12%
2015-12-31C$0.16 B399.83%
2014-12-31C$33.98 M-48.53%
2013-12-31C$66.03 M79.15%
2012-12-31C$36.85 M27.89%
2011-12-31C$28.82 M291.21%
2010-12-31C$7.36 M-58.06%
2009-12-31C$17.56 M-54.68%
2008-12-31C$38.76 M-35.54%
2007-12-31C$60.12 M-8.49%
2006-12-31C$65.7 M149.94%
2005-12-31C$26.28 M-30.07%
2004-12-31C$37.59 M20.69%
2003-12-31C$31.14 M

Cash on Hand for similar companies or competitors

Company Cash on Hand differencediff. Country
C$0.52 B-60.48%๐Ÿ‡บ๐Ÿ‡ธ USA
C$0.17 M-99.99% Bahamas